Inmar announced today that it has entered into an agreement to acquire Capital Returns. Through this acquisition, Inmar will combine the strengths of both companies to continue to drive improvements to pharmaceutical supply chain security, data capture and exchange, and additional regulatory expertise and quality for manufacturers, retailers, long-term care, health systems and wholesalers.